Structural requirements for pairing of alpha and beta chains in HLA-DR and HLA-DP molecules by unknown
STRUCTURAL REQUIREMENTS FOR PAIRING OF
a AND (3 CHAINS IN HLA-DR AND HLA-DP MOLECULES
BY DAVID R. KARP,' CHRISTINA L. TELETSKI,'
DOLORESJARAQUEMADA,' W . LEE MALOY,I
JOHN E. COLIGAN,I AND ERIC O . LONG'
From the 'Laboratory of Immunogenetics and IBiological Resources Branch, National Institute
ofAllergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892
Theclass II antigens ofthehuman MHC are cell surfaceheterodimers composed
of noncovalently linked 35-kD a chains and 29-kD (3 chains . These antigens are
present on macrophages, B lymphocytes, and otherAPC (for review, seereference 1).
Class II antigens are capable of binding immunogenic peptides and thereby serve
as ligand for theTCR (2, 3) . Recent experiments have demonstrated that class II
proteins are also functional ligands for the T cell surface antigen CD4 (4-6) .
Class 11 antigens display avery high degree ofallelic polymorphism, presumably
to enable the species to mount the widest possible range of immune responses . At
the individual level, diversity in class II antigens is provided by theexistence ofthree
isotypic forms in man, namedHLA-DR,HLA-DQ, andHLA-DP. These isotypes
are characterized by nonpolymorphic sequences unique to each isotypic a and a
chain. HLA-DR, the immunodominant class II isotype, has a nonpolymorphic a
chain andahighly polymorphicachain. Most ofthe allelic variation in DR achains
is concentrated in three regions located in the NHz-terminal half of the molecule,
termed the01 domain. Extensive allelic variability is also located in the firstdomain
of the DQa, DQ3, and DPS chains (7, 8) .
A third form of diversity is possible if thea chain of one isotype pairs with the
(3 chain of another, creating a so-called mixed isotypic pair. Such pairings have not
been demonstrated on APC in vivo usingavailablemonoclonal and polyclonal sero-
logical reagents . The pair DRa/DQ3 has been found in particular transformed B
cell lines that express high levels of the DRa chain (9) . Modulation of the level
ofexpression ofDR achains inB cell linescontrolled the formationof theDRa/DQ8
pair, in that only cells expressing high levels ofDRamRNA produced this mixed
isotypic pair (10) . Cell surface expression of mixed isotypic pairs was detected in
cells transfected with different combinations ofa and 0 chains, presumably because
high levels ofmRNA for each chain were produced in those cells (11) .
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The murine counterpart of the DRa/DQf3 pair, namely Ea/A/3, was expressed
at the surface of transfected cells (12, 13), and was detected biochemically on a par-
ticular B cell lymphoma (14) . Only the A/3 chain from the H-2d haplotype was able
to pair with the Eat chain, and this permissive pairing was controlled by the first
50 amino acids of the A/3 chain (15). Expression of the mixed isotypic pair Ea/A(3
in cells cotransfected with isotypically matched chains occurred only ifthe mismatched
chain was present in excess, suggesting an inefficient assembly of the mixed isotypic
pair (16). It is not known whether the nonpermissive combinations ofmixedisotypic
pairs fail to be expressed because they do not assemble intracellularly, or because
of a defect in transport to the cell surface.
In this report, we present the development of an efficient transient transfection
system for the expression of mutated human class II cDNA molecules. It was pos-
sible to demonstrate the presence ofDR and DP antigens both by cell surface staining
and by metabolic labeling. Mixed isotypic pairs did not assemble efficiently and were
not detected at the cell surface. Using a series ofchimeric (3 chain cDNAs containing
DR and DP sequences transfected into cells expressing either the DR or DP a chain,
regions ofS sequence that are important for isotypic pairing were identified. These
regions are different for DR and DP, and suggest that there are important constraints
on secondary and tertiary structure that determine the ability of a given a chain
to form a stable heterodimer.
Materials and Methods
Tissue Culture.
￿
The murine fibroblastic cell line DAP-3 (17) was used throughout the ex-
periments. Cells were maintained in DME, high glucose formulation (Hazleton Biologics,
Inc., Lenexa, KS), supplemented with 10% heat-inactivated FCS, 2 mM glutamine, 1 mM
sodium pyruvate, 10 mM Hepes buffer, pH 7.4, and 10 lAg/ml gentamicin. Medium for the
selection of cells transfected with the bacterial gpt gene (see below) consisted of DME sup-
plemented as aboveplus mycophenolic acid (6,ug/ml), xanthine (0.25 mg/ml), and hypoxan-
thine (15 lAg/ml) (MXH)' (18).
Antibodies.
￿
The following mAbs were used: SG465, anti-human class II (19); SG520, anti-
DR,DPS chain (20); SG171, anti-DR,DP /3 chain (21) (generously provided by Dr. S. Goyert,
Cornell University Medical College); 1135, anti-DR a chain (provided by Dr. J. Bodmer ICRF,
London) (22); and P4H5, a hamster mAb to murine invariant chain (Dr. S. Cullen, personal
communication). Rabbit antisera to synthetic peptides corresponding to the COOH termini
of DR or DP fl chains were prepared as described (23). Briefly, synthetic peptides were pre-
pared corresponding to the COOH-terminal 10 and 11 residues of the DR1 or DP2 /3 chains,
respectively. These peptides were coupled to keyhole limpet hemocyanin via an additional
NH2-terminal cysteine residue. The peptide-carrier conjugate (2001.ag) was mixed with CFA
and injected subcutaneously. The rabbits were boosted at 2, 3, and 13 wk by the injection
of an additional 200 Kg of antigen in IFA. Sera were obtained 2 wk after the last injection
and tested by antipeptide ELISA.
Stable Transfections.
￿
DAP-3 cells (5 x 105/100-mm dish) were transfected using the calcium
phosphate coprecipitation technique (24). 15 p,g of the recombinant plasmids RSV5 DRa
or RSV.5 DPa were used foreach transfection. These plasmids contain both the classII cDNA
under the control of the Rous sarcoma virus long terminal repeat (RSV LTR), as well as
theEscherichia coli guanyl phosphoribosyl transferase gene under the control ofthe SV40 early
promoter. Their construction will be described elsewhere. 2 d after transfection, the cells
were placed into MXH-containing medium. Surviving cells were cloned by limiting dilu-
tion. Individual clones were tested for expression of the a chain cDNA either by mRNA
determination, or by the expression ofdimeric class II molecules after transient transfection
of class 11 0 chains (see below).KARP ET AL . 617
Construction ofa ReplicatingcDNA Expression VectorforMurine Cells .
￿
The eukaryotic expres-
sion vector RSV3 contains the RSV LTR, a multiple cloning site from pUC12, and SV40-
derived polyadenylation sequences plus pBR322 sequences for bacterial replicationand am-
picillin resistance (25) . To facilitate later cloning, this vector wasdigested at theunique Hind
III site at the Tend of the small polylinker region, repaired with Klenow, and a Cla I linker
was added . The resultant plasmid was then linearized at the Bam HI site at the 3' end of
the SV40 termination sequences . This DNA was ligated to a 3.6-kb fragment derived by
digestingtheplasmidpSV5-neo with Bam HI (26) . This fragment contains the entire polyoma
virus early region, including the origin of replication and genes for the small, middle, and
largeTantigens. The resultantplasmid, termed R3CPy-II (Fig. 1), contains two unique sites
forcDNA insertion: Cla IandSal I . Formost ofthe class II constructs (see below) this vector
was digested with both of these enzymes to allow directed cloning.
Generation ofMutant and Chimeric Class 11,8 Chains.
￿
Inspection of thecDNA sequences for
the DRl and DP2 a chains (27) revealed several positions where either a unique restriction
site already existed at the same place in eachcDNA, or could be created by oneor twopoint
mutations (Fig . 2). The mutations required to accomplish this are given in Table I. First,
the cDNAs for the DRl and DP2,6 chains were removed from the original cloning vector
(27) with the enzymes Sma I and Bam HI, and the Barn HI site was filled in with Klenow
enzyme . ThecDNAs were then cloned intoaKlenow-repaired Sal I site in the vectorBluescript
SK(-) (Stratagene, LaJolla, CA). Recombinantplasmids were analyzed for the orientation
of the insert, and clones with the Tend of the cDNA nearest the Cla I site of thevector were
identified . ThecDNA with the vector-derived flanking Cla I and Xho I sites was removed
with the enzymes EcoRI and Kpn I, and inserted into replicative form ofM13mpl9 digested
with the same enzymes.
Mutagenesis wasperformed on these recombinant phages using the Mutagene Kit (Bio-
Rad Laboratories, Richmond, CA) as directed by the supplier. Synthetic oligonucleotide
primers for themutagenesis were 36 mers produced on aDNA synthesizer (38013 ; Applied
Biosystems, Inc., Foster City, CA) and purified by PAGE. The presence of the desiredmuta-
tionswasdetermined byDNAsequencing usingthechain termination method (28). Efficiency
o£ the mutagenesis was typically 75-100% .
Replicative form DNA was generated from M13 clones with verified mutations . This was
digested with Cla I and Xho 1, and the resultant mutant class II cDNA was isolated from
a lowmelting pointagarose gel . This insert was then cloned into either theexpression vector
for functional analysis or Bluescript for further manipulation .
Chimeric 0 chain cDNAs were generated by digesting the wild-type or mutant class II
chaincDNA cloned into Bluescript with either Cla I orXho I andthe restriction endonuclease
FIGURE 1.
￿
R3CPy-II, a polyoma-based eukaryotic expres-
sion vector. Avector for transient expression ofcDNAswas
constructed by ligation of aDNA segment containing the
polyoma virus early region into the expression vectorRSV.3
containingthe ampicillin resistance gene, the bacterial origin
ofreplication, the RSV LTR, and the SV40 poly(A) addi-
tion sequences (AAA). The direction of transcription of
the early region genes, andthe twounique cloningsites for
cDNA insertion, are indicated.61 8
￿
STRUCTURAL REQUIREMENTS FOR CLASS II odO CHAIN PAIRING
specific for the mutated site . DNA fragments containing 5' sequences of one class II isotype
were ligated to those coding for 3' segments of the other isotype in the Bluescript vector. The
resulting chimeric /3 chain cDNAs were then excised with Cla I and Xho I and cloned into
the replicating expression vector. The authenticity of all constructs used for transfection was
verified by restriction endonuclease digestion andDNA sequencing ofthe chimeric boundaries .
The chimera at amino acid 59 was constructed using the unique Sca I site common to
all human class 11 0 chain DNA sequences . Recombinant plasmids containing the wild-type
DR orDP (3 chain cDNA in the Bluescript vectorwere digested with Sca I and Cla I to generate
three fragments : a Cla I to Sca I fragment consisting of 5' cDNA sequences, a Sca I to Sca
I fragment containing 3' cDNA sequences and vector sequences including one half of the
ampicillin resistance gene, and an Sca I to Cla I fragment containing the remainder of the
amp` gene . The fragments were separated using low melting point agarose and the appro-
FIGURE 2 .
￿
Position of mutations created in class II cDNAs. A schematic diagram of a human
class II (3 chain is shown. The positions of the signal peptide (sig), 01 domain, 02 domain, con-
necting peptide (cp), transmembrane region (tm), and intra-cytoplasmic portion (cyt) are shown.
HVl, -2, and -3 refer to the hypervariable regions of allelic diversity. The location of the single
N-linked oligosaccharide is indicated by a diamond . The numbers 1, 2, and 4 refer to the posi-
tions ofunique restriction endonuclease sites that were created by site-directed mutagenesis . Site
3 is the conserved Sca I site present in DR and DP R chain cDNA sequences . These four sites
form the junctions for the chimeric cDNA molecules constructed between the DR and DP (3
chain sequences .
TABLE I
Mutations Required to Create Unique Restriction Sites
` Location of the unique restriction endonuclease site generated by site-directed mutagenesis, as shown in
Fig . 2 . Site 3 uses a unique Sca I site already present in DR and DP S chains .
t Class II ,B chain .
s Sequences fromDR1 and DP2 from reference 27 . The derived amino acid sequence is shown above the
DNA sequence . The nucleotide(s) that were mutated are shown in boldface . Superscript numbers indicate
the position of the recognition sequence according to DR# numbering .
1 Amino acid changes as a result of mutagenesis are shown . A dash indicates no change .
Site` Enzyme
Recognition
sequence Isotypel Original sequences Mutated sequences)
22 Q R F
1 Eco47 III AGCGCT DP CAG CGC TTC GAG CGC TTC
DR GAG CGG GTG GAG CGC TTG
E R V - - L
43 D _V
2 Aat II GACGTC DP GAG GTG GAG GTC
DR GAG GTG GAG GTC
D V
yr P R
4 Avr II CCTAGG DP CCT AGG CCT AGG
DR CCT AAG CCT AGG
P K - RKARP ET AL.
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priate DNA segments religated to generate the DR:DP and DP:DR chimeras. The chimeric
cDNAs were put into the expression vector and the sequences verified as above.
The nomenclature of the chimeric f3 chains is as follows. The relative order of the two
isotypes involved and the position of the first amino acid in the endonuclease recognition
sequence is given (using the DRl 13 chain numbering in reference 27). For example, RP22
is a 0 chain with an NH2 terminus derived from DRl and a COOH terminus derived from
DP2, which is chimeric at the Eco 47 III site in the cDNA coding for amino acid 22 .
Transient Transfections.
￿
The ability of chimeric class II f chains to pair with either DR or
DP a chains was tested by transfecting their cDNA into fibroblasts stably expressing the a
chain (above). 5 x 105 cells were plated in each T-25 tissue culture flask on the day before
transfection. The next day, 5 jig ofsupercoiled plasmid DNA was diluted with 0.5 ml ofserum-
free DME for each flask. This was mixed with an equal volume of serum-free DME con-
taining 1 mg/ml ofDEAE-dextran (Pharmacia Fine Chemicals, Piscataway, NJ) and 100 pM
chloroquine diphosphonate (Sigma Chemical Co., St. Louis, MO). The cells were washed
twice with serum-free medium, and the DNA-containing solution (1 ml) was added to the
cell monolayer. The cellswere incubated with occasional rocking for 3 h in a humidified 37°C
incubator. The DNA solution was then removed from the cells and replaced with complete
medium for 24 h, then changed to complete medium supplemented with 10 mM sodium
butyrate (Sigma Chemical Co.).
48 h after transfection, the cells were collected with trypsin/EDTA and incubated with
saturating amounts of various mAbs on ice for 30 min. The cells were then washed and stained
with fluoresceinated goat anti-mouse Ig. After the final wash, the cells were suspended in
PBS containing 20 ug/ml propidium iodide (Calbiochem-Behring Corp., LaJolla, CA). Cells
were analyzed on the FACScan flow cytometer (Becton Dickinson & Co., Mountain View,
CA). A minimum of 104 live cells were analyzed.
Metabolic Labeling.
￿
Cells that had been transiently transfected with cDNAs for wild-type
or chimeric class110 chains were methionine starved by a 1-h incubation in methionine-free
MEM supplemented with 10% dialyzed heat-inactivated FCS. This medium was then replaced
by medium containing 0.25 mCi of "S-methionine/ml (1 Ci = 3.67 x 10'° Bq). After 6 h
at 37°, the cells were collected and washed extensively. They were then lysed in a buffer con-
taining 0.5% NP-40, 0.15 M NaCl, 50 mM Tris/HCI, pH 7.5, 10 mM EDTA, 10 mM iodo-
acetamide, 10 MM t.-methionine, and 1 mM PMSE After 15 min on ice, the nuclei were
spun out and the lysates precleared overnight at 4°C with I% (vol/vol) normal rabbit or mouse
serum and 10% (vol/vol) preswollen protein A-agarose. After microcentrifugation, the ly-
sates were cleared a second time with 1 :20 vol protein A-agarose. The cleared lysates were
then immunoprecipitated with a combination of 1:20 vol ofmAb and 1:20 volume of protein A-
agarose for 2 h at 4°C. The precipitates were washed twice with lysis buffer made 0.5 M
with NaCl, twice with lysis buffer made 0.25 M with NaCl, and once with lysisbuffer alone.
The pellets were solubilized by heating in 2% SDS and subjected to electrophoresis in 12%
polyacrylamide gels under nonreducing conditions (29). The gels were fixed, soaked in
En3Hance (Dupont-New England Nuclear, Pittsburgh, PA), dried, and exposed to Kodak
X-omat film at -70°. The Mr was determined using '4C-methylated protein molecular
weight standards (Amersham Corp., Arlington Heights, IL).
Results
Expression ofHuman Class II cDNAs in a Polyoma-based Replicating Vector.
￿
To rapidly
analyze wild-type and mutant class II molecules, the vector R3CPy-II was constructed
(Fig. 1). This vector contains sequences for bacterial replication and ampicillin re-
sistance from pBR322, the RSV LTR to direct expression ofinserted cDNAs, SV40
termination sequences, and the entire polyoma virus early region. Full-length, ex-
pressible cDNAs for the class II a and a chains were cloned into this vector. Murine
fibroblasts were transfected with these recombinant plasmids and analyzed by flow
microcytofluorimetry 48 h later. Initially, L cells were transfected with replicating
plasmids for both the class II a and 0 chains simultaneously (not shown). However,620
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it was determined that higher levels of class II expression could be obtained ifeither
thea or,3 chain was stably transfected and the partner chain transiently transfected.
Using this technique, 30-50% of the cells express class II molecules on the cell sur-
face (see below).
Expression ofMatched, butnotMixedIsotopic Class IIMolecules.
￿
Lcells that had been
stably transfected with either the DR or DP a chain were then transiently trans-
fected with the DR and DP ,8 chains encoded by the polyoma-based vector (Fig.
3). Only the matched isotypic pairs (DRa/DRO and DP&DPO; Fig. 3, A and D,
respectively) are expressed at the cell surface as detected by the antibody SG465,
which reacts with allnative classII molecules (19). The mixed isotypic pairs(DRa/DP#
andDPot/DRfl; Fig. 3, Band C, respectively)were not detected. These transfectants
were also stained with L243 (anti-HLA-DR), 137-21 (anti-HLA-DP), and SG171 and
SG520 (both anti-class II (3 chain). In all cases, only transfections of matched iso-
typic pairs were detected by these antibodies (not shown). In addition, transfections
of the HLA-DQ a anda chain cDNAs along with DR or DP subunit cDNAs did
notresult in detectable cell surface class II expression, whereas the DQa/DQ3com-
bination was easily detected with SG465 (not shown).
Intracellular Pairing ofMixedIsotopic Class 11 Molecules Is Inefficient.
￿
It was possible
that mixed isotypic pairs were being formed, but that they were either not being
transported to the cell surface, or that the antibody SG465 required the presence
of a conformational determinant present only on normal pairs. To investigate these
possibilities, cells stably expressing the DR or DP a chains were transfected with
either the DR or DP (3 chain cDNAs, and class II proteins were biosynthetically
radiolabeled with 35S-methionine, detergent solubilized, and immunoprecipitated
with rabbit antisera directed to distinct COOH-terminal ,f3 chainprotein sequences.
The immunoprecipitates were then analyzed by nonreducing SDS-PAGE. As shown
in Fig. 4, a significant amount of either the DR or DP ,6 chain is synthesized in
allcellstransiently transfected with replicating expression vectors (Fig. 4, lanes C-F).
However, only in the cells containing the homologous isotopic pairsDRa/DRf(Fig.
4, lane C) or DP&DPO (Fig. 4, lane F) does a significant amount of the a chain
coprecipitate with thea chain. As shown in Fig. 4, lane A, the murine class II-as-
sociated invariantchainmigratesjust below the achainin this electrophoreticsystem.
- a
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FIGURE 3. Transient transfection of
murine fibroblasts with human class II
cDNAs. L cells stably transfected with ei-
ther theDR (A and B) or DP (C andD) a
chain cDNA were transiently transfected
with replicating expression vectors con-
tainingtheDRI SchaincDNA (A andC)
ortheDP20chaincDNA (B andD). Cells
were stained with mAb SG465 48 h after
transfection and analyzed by microcyto-
fluorimetry.It is intensely labeled due toa high methionine content. The invariant chain is only
associated with paired a/fl dimers . It is not coprecipitated with either the a chain
(Fig . 4, lane B) or (3 chain alone (Fig . 4, lanesDand E). The band migratingahead
of theinvariant chain corresponds to theexpected position ofp25, a proteolytic frag-
ment of the invariant chain (30) .
Expression of Chimeric DRIDP,8 Chains with DR andDPa Chains .
￿
To ascertain
the important a chain sequences necessary for pairing with the matcheda chain,
chimeric a chain cDNAs were constructed . These constructs createda chains that
had both DR and DP sequences . The positions of the crossover from one isotypic
sequence to the other is shown in Fig. 2 . In cases where the mutation needed to
create the unique restriction site for chimera construction caused an amino acid
change, an additional construct was made containing only that mutation within the
wild-type DR or DP sequence . This a chain was tested along with the chimeras
for association with both DR and DP a chains .
Fig . 5 shows the results of transient transfections of class 11 0 chains containing
DR and DP sequences chimeric at the junction between the (31 and 02 domains
(amino acid 97) into murine fibroblasts stably expressing the DR or DP a chains .
The (3 chaincontainingDR 01 andDP /32 sequences (RP97) was able to pair efficiently
FIGURE 4 .
￿
Metabolic labeling of class II molecules in tran-
siently transfected L cells. Cells stably expressing theDR a
chain (lanes A-D) or DP a chain (lanesE andF) were tran-
siently transfected with the replicating vector withoutacDNA
insert (lanes A and B), with theDR R chain cDNA (lanes C
andE), or with the DP S chain cDNA (lanesDand F) . 48 h
after transfection, the cells were labeled with "S-methionine.
Immunoprecipitates of cell lysates usingP4H5 (antimurine in-
variant chain, lane A), 1135 (anti-DRachain, lane B),or rabbit
antisera directed againsttheCOOH terminus of the DR 0chain (lanes CandE) or DP (3 chain (lanes
D and F) were analyzed by nonreducing SDS-PAGE . The relevant portion of a 12% polyacrylamide
gel is shown . The position of the class II a and 0 chains and the class II-associated invariant chain
(In) are indicated . Theband migrating aheadofthe invariantchain in laneA is aproteolytic fragment,
p25 (30) .
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FIGURE 5 . Cell surface expression of
class II molecules with chimeric S chains.
Cells expressing the DR a chain (A and
B) or DP a chain (C and D) were tran-
siently transfected with replicating vectors
containing chimeric /3 chaincDNAs . The
cDNAused inA and Ccontains the Sl do-
main of DR and the 62 domain of DP
(RP97) ; that used in BandD has the Sl
domain ofDP and the 02 domain ofDR
(PR97). Theexpression of class II was de-
termined by staining the cells with anti-
body SG465 and microcytofluorimetric
analysis .622
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and be expressed at the cell surface (asjudged by staining with SG465) only with
the DR a chain. Conversely, aa chain having DP 01 and DR 02 sequences (PR97)
would only pair with the DP a chain, although the level of expression per cell was
lowerthan that seen in the DRa/RP970 combination. Thus, the presence ofisotyp-
ically matched /31 sequences alone was sufficient to allow pairing.
The results of transfection of /3 chain cDNAs chimeric between DR and DP se-
quences at amino acids 22, 43, and 59 into DR and DP a chain-containing cells
are summarized in Table II. Staining the cell surface with an anti-human class II
reagentdemonstrated that the DR achainwould pair and be expressed with /3 chains
having DR sequence up to amino acid 22, as well as chimeras having DP sequence
in their NH2 termini up to positions 43 and 59. In addition to pairing with the
PR97 a chain, the DP a chain was able to pair and expresswith thePR43 and PR59
(3 chains (which also paired with DRa). The PR22, RP43, and RP59 /3 chains were
unable to pair and express with either the DR or DP a chain, asjudged by cell sur-
face staining with anti-DR (L243), anti-DP (B7-21), or anti-a chain (SG171 and
SG570) mAb (data not shown).
MetabolicLabelingofHuman Class IIMolecules Containing Chimeric (DRIDP),!I Chains.
As before, the apparent lack of expression of certain chimeric /3 chains with DR
or DP a chains could be explained simply by either a lack of the appropriate mAb
epitope, or by lack ofsurfaceexpression of intracellular a/(3 dimers. To address both
of these issues, cells stably expressing the DR or DP a chains were transfected with
wild-type or chimeric (3 chains, labeled with 35S-methionine, and lysed, and the ly-
sateswere immunoprecipitated with rabbit anti-COOH-terminal sera as above. The
immunoprecipitates were separated on nonreducing polyacrylamide gels (Fig. 6).
TABLE II
Transfection of,l3 Chain cDNAs Chimeric between DR and DP Sequences
into DR and DP a-containing Cells
` L cells expressing either the DR or DP a chain were transiently transfected
with class 11 0 chains that were chimeric for DR and DP sequences (see text
for details). After 48 h, the cells were analyzed for surface expression of hu-
man class II by microcytofluorimetry.
Percentage of cells binding the mAb SG465.
4 Level of fluorescence intensity determined by the ratio of the mean fluores-
cence intensity of the SG465' cell population to the mean fluorescence inten-
sity of the cells stained with goat anti-mouse IgG alone. Representative values
for the transient expression of the unmutated isotypes are 30-50% positive
cells at a level 22 times background for DR, and 30-35% positive cells at a
level 22 times background for DP.
Chimeric
(3 chain`
DRa
Percentt Level§
DPa
Percent Level
RP22 40 14 0 -
RP43 0 - 0 -
RP59 0 - 0 -
RP97 54 13 0 -
PR22 0 - 0 -
PR43 41 35 55 73
PR59 48 4 29 29
PR97 0 - 22 3KARP ET AL.
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FIGURE 6 .
￿
Metabolic labeling
of cells transfected with chi-
meric class II fl chain cDNAs .
L cells stably transfected with
the DR a chain (A) or DP a
chain (B) were transiently trans-
fected with the indicated chi-
mericSchain cDNAs . Metabol-
ically radiolabeled proteins were
immunoprecipitated with rabbit
antisera specific for theCOOH
terminus ofthe chimeric0chain
(DR or DP) and analyzed as in
Fig . 4. The position ofthe class
II a and Q chains are indicated .
The surface staining of cells with the antibody SG465 correlated with the presence
of significant intracellular pairing of thea and (3 chains . Those combinations that
were not detected at the cell surface resulted in little or no a chain coprecipitated
with the /3 chain . Therefore, the lack ofexpression is due to poor initial a/O pairing,
rather than a defect in transport of intracellular dimers to the cell surface, or a lack
of antibody binding.
With one exception, the biosynthetically labeled (3 chain chimeras migrate as poorly
defined bands of heterogeneous mobility. ThePR97 /3 chain migrates as a distinct
doublet . The variation in the pattern of (3 chain migration from onechimerato an-
other is highly reproducible (Fig . 6, A and B) . It is not known whether this vari-
ability in mobility represents differences in intra-chain disulfide bond formation,
differences in post-translational processing, or merely the effect of different amino
acid compositions .
Discussion
At present, the exact nature of the structure of class II molecules is unknown.
The three-dimensional structurecan be inferred by comparison to a class I molecule
for which a crystal structure has been obtained (31) . The alignment of sequences
andpreservation ofaminoacid residues essentialfor tertiary structure (e.g., disulfide
bonds and salt bridges) provides presumptive evidence for the schematized struc-
ture shown in Fig . 7. Such modeling alone cannot predict whether there will be iso-
typic differences in the exact three-dimensional structure of class II, nor whether
the lack ofmixedisotypic pair expression at the cell surface isdueto intrinsic incom-
patibilities between the a and /3 chains of different isotypes .
The experiments described in this report were designed to answer some of these
questions . Specifically, whether mixed isotypic pairs of human class II molecules
form intracellularly, whether they are expressed at the cell surface, and which parts
of the class 11 0chains are important forthe ability to pair witha chains . To address
these questions efficiently, a polyoma-based transient transfection system was devel-
oped . The expression vector uses theRSVLTR as apromoter forthe inserted cDNA .
This promoter has been shown to be very active in a variety of eukaryotic cells (32) .
In particular, it has been used previously in stable transfectionsofLcellswith human624
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FIGURE 7 .
￿
Model of the class II antigen-binding
site . A model of the three-dimensional structure of
the al and01 domains of class II is shown (adapted
from reference 31 with permission of the authors).
Thenumbers indicate the approximate positions of
the sites used to create chimeric class 11 0 chains be-
tween DR and DP sequences . Amino acid 22 is in
the region between the first two0 strands, 43 is be-
tween the thirdand fourth0 strands, 59 is in the be-
ginning of the a helix, and 97 is at the beginning
of the02 domain . The parentheses mark the region
of the 0 chain where the DP sequence has a two-
amino acid deletion compared with DR (ADP) .
class II a and 0 chains (25) . The polyoma virus early region in the vector, R3CPy-
11, contains the polyoma origin of replication as well as genomic sequences for the
three early proteins, large, middle, and smallT antigens . LargeT antigen is neces-
sary for viral (and vector) replication and is responsible for immortalization of cells
(33) . Middle T antigen is necessary for the induction of the transformed phenotype
(34) . SmallT antigen serves to enhance the level of viral replication (35) . Although
the presence of middle and smallT antigens is not absolutely necessary forpolyoma
replication, they were included in the expression vector in an attempt to maximize
the potential amount of class 11 mRNA present in the cell . A similar vector con-
tainingthe polyoma virus earlyregion waspreviously used forexpression ofgenomic
clones encoding Ig H chains (36) .
In our transient system, all three isotypes ofhuman class II can be individually
expressed at the surface ofmurine fibroblasts . They form the appropriate heterodi-
mers intracellularly, and bind to the murine invariant chain during biosynthesis .
They each retain reactivity for specific and broadlyreactive anti-class 11mAbs . Thus,
these class II molecules appear to be identical to the class 11 molecules synthesized
in humanAPC. The demonstration of inefficient mixed isotypic pairing is unlikely
to be due to the experimental system, even though minor species- or tissue-specific
differences in post-translational modifications, such as carbohydrate processing, cannot
be ruled out . Expression of a mixed isotypic pair, such as DRa/DQß, probably re-
quires high intracellular levels ofthesechains, together with the availability of achain
present in excess over its isotypic partner (10) . Such mixed isotypic molecules are
probably rareand are unlikely to contribute functionally to class II antigen diversity .
The lack of expression of mixed isotypic molecules in the transient transfection
system made it possible to test which regions of class 110 chains were important
for pairing with a chains . A series of chimeric 0 chains was constructed between
DR and DP 0 chain sequences . The expression pattern of these chimeras with the
DR or DP a chains leads to two immediate conclusions. First, that HLA-DR and
HLA-DP are structurally different insofar as their requirements for cdo pairing .
For example, the chimeric 0 chain RP22, having only the first 22 amino acids of
the DR 0 chain sequence, is sufficient to pair with the DR a chain . The PR22 0
chain does not pair with theDP a chain . The DP a chain will pair efficiently with
a chimeric 0 chain having DP sequences for the first 43 amino acids (PR43) . TheKARP ET AL.
￿
625
converse S chainchimera, RP43, does not pair with the DR a chain. Similar results
are found with R chain chimeras centered around amino acid 59.
The second conclusion is that since the pairing of a and 0 chains ofdifferent iso-
types cannot be accounted for simply on the basis of primary sequence, then sec-
ondary andtertiary structural considerations must play an important role. The model
of the class II antigen-binding site developed by Brown et al. (31) (Fig. 7) can serve
as a useful model for the interpretation of the data in this report. The pairing of
the RP22 (3 chain with the DR a chain implies an interaction between the two /3
strands in the center of the floor of the antigen-binding site. In the case of the DP
(3 chain, additional (3 sheet structure (amino acids 1-43) is needed to pair efficiently
with the DP a chain. The pairing of the PR43 and PR59 a chains with both the
DR and DP a chains, and the lack of pairing of the RP43 and RP59 (3 chains with
either a chain, have several possible explanations. First, there is a two-amino acid
deletion in the DP (3 chain sequence relative to the DR sequence just after amino
acid 22 . Although the DR and DP achains are ofidenticallength, the tertiary struc-
ture of the DP a chain may have evolved to compensate for this deletion. In addi-
tion, the pairing pattern of these chimeras may demonstrate the effects of different
regions ofa//3 interaction. The failure of RP43 and RP59 /3 chains to assemble with
a chains may reflect specific interactions between the a helix and the underlying
/3 strands in DP /3 chains. Further, the pairingof the PR43 andPR59 (3 chains with
the DR achainmay implythat there is significant interaction between thea-helical
portions of the 01 domain (amino acids 59-97) of DR and portions of the DR a
chain. Studies with a chain chimeras will provide additional insight on this point.
A different structure for the DR and DP NH2-terminal domains would have im-
portant implications in class II antigen function. For example, the nature of im-
munogenic peptides that bind to DP may be different than those that bind to DR.
In this way, different isotypes of class II would serve to broaden the immune re-
sponse of an individual by presenting a wider array of antigens. In addition, there
may be differences in the way class II molecules interact with the TCR, or with
coreceptor molecules such as CD4. Finally, there have been several recent reports
that bacterial toxins that serve as "super antigens," activating T cells in vitro, bind
directly to class II molecules (37, 38). There is a definite hierarchy of binding to
different class II isotypes among the various toxins tested. The molecular basis for
these differences should be readily testable using class II molecules with chimeric
and point-mutated a and a chains.
Summary
To test for the assembly of human MHC class II molecules having an a chain
from one isotype (HLA-DR, -DQ, or -DP) and the (3 chain of another (mixed iso-
typic pairs), murine fibroblasts were transfected with expressible cDNAs encoding
thedifferentclass II a and /3 chains. A rapidandefficienttransienttransfection system
was developed using a polyomavirus-based vector. Typically, 30-50% of cellstrans-
fected using this system expressed high levels of class II molecules on their surface,
but only with matched isotypic pairs. Biochemical analysis of cells transfected with
matched or mixed isotypic pairs of the DR and DP molecules revealed that only
matched chains could pair efficiently inside the cell. Thus, the lack of expression626
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of the two mixed isotypic pairs is due to inefficient primary assembly of the class
II molecule and not to a processing or transport defect.
To define what region of the (3 chains controlled their assembly with a chains,
a series ofchimeric cDNA molecules containing both DR and DP 0 chain sequences
were constructed. Expression of these chimerica chains with DR and DP a chains
was determined by cytofluorimetry and biochemical analysis. Both a chains paired
with (3 chains in which only the 01 domain was isotypically matched. In contrast,
the pattern of expression of chimeras made at other points within the /31 domain
was different for DR and DP These data show that different areas of primary se-
quence are important for the assembly ofdifferent human class 11 isotypes, and sug-
gest that HLA-DR and -DP molecules have different secondary or tertiary struc-
tures in their NH2-terminal domains.
We thank Ms. Vicki Pelak for oligonucleotide synthesis, and Drs. Sana Goyert, Julia Bodmer,
and Susan Cullen for antibodies.
Receivedforpublication 12 October 1989.
References
1 . Kaufman, J . F., C. Auffray, A. J. Korman, D. A. Schackleford, and J. L. Strominger.
1984. The class II molecules of the human and murine major histocompatibility com-
plex. Cell. 36:1.
2. Unanue, E. R., and P M. Allen. 1987. The basis for immunoregulatory role of macro-
phages and other accessory cells. Science (Wash. DC). 236:551 .
3 . Sette, A., S. Buus, S. Colon, J . A. Smith, C. Miles, and H. M. Grey. 1987. Structural
characteristics of an antigen required for its interaction with Ia and recognition by T
cells. Nature (Lond.). 328:395.
4. Gay, D., P. Maddon, R. Sekaly, M. A. Talle, M . Godfrey, E. Long, G. Goldstein, L.
Chess, R. Axel,J. Kappler, and P Marrack. 1987. Functional interaction between human
T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen. Nature
(Loud.). 328:626.
5. Sleckman, B. P, A. Peterson, W K. Jones, J. A.. Foran, J. G. Greenstein, B. Seed, and
S. J. Burakoff. 1987. Expression and function of CD4 in a murine Tcell hybridoma.
Nature (Lond.). 328:351 .
6. Lamarre, D., D.J. Capon, D. R. Karp, T Gregory, E. O. Long, and R.-P. Sekaly. 1989.
Class II MHC molecules and the HIV gp120 envelope protein interact with functionally
distinct regions of the CD4 molecule. EMBO (Eur Mol. Biol. Organ.)f. 8:3271.
7. Trowsdale, J.,J. A. Young, A. P. Kelly, P. J. Austin, S. Carson, H. Meunier, A. So, H . A.
Erlich, R. S. Spielman, J. Bodmer, and W F. Bodmer. 1985. Structure, sequence, and
polymorphism in the HLA-D region. Immunol. Rev. 85:5.
8. Korman, A. J., M. Boss, T. Spies, R. Sorrentino, K. Okada, andJ. L. Strominger. 1985.
Genetic complexity and expression of human histocompatibility antigens. Immunol. Rev.
85:45.
9 . Lotteau, V., L. Teyton, D. Burroughs, and D. Charron. 1987. A novel HLA classII mole-
cule (DRa-DQf3) created by mismatched isotype pairing. Nature (Loud.). 329:339.
10 . Lotteau, V., J . Sands, L. Teyton, P Turmel, D. Charron, and J. L. Strominger. 1989.
Modulation of HLA class II antigen expression by transfection of sense and antisense
DRa cDNA. f. Exp. Med. 169:351.
11 . Long, E. O., S. Rosen-Bronson, S. Jacobson, and R. P Sekaly. 1990. Isotypic diversity
and function of HLA class II molecules. In Molecular Biology of HLA Class II An-
tigens. J. Silver, editor. CRC Press. Boca Raton, FL. In press.KARP ET AL.
￿
627
12 . Germain, R. N., and H. Quill. 1986. Unexpected expression ofa unique mixed-isotype
class II MHC molecule by transfected cells. Nature (Lond.). 320:72.
13. Malissen, B., N. Shastri, M. Pierres, and L. Hood. 1986. Cotransfer of the Ecrd and A,$d
genes into L cells results in the surface expression of a functional mixed-isotype la mole-
cule. Proc. Nail. Acad. Sci. USA. 83:3958.
14. Spencer, J. S., and R. T. Kubo. 1989. Mixed isotype class 11 antigen expression: a novel
class II molecule is expressed on a murine B cell lymphoma. 1989. J Exp. Med. 169:625.
15. Sant, A. J., N. S. Braunstein, and R. N. Germain. 1987. Predominant role of amino-
terminal sequences dictating efficiency ofclass II major histocompatibility complex as
dimer expression. Proc. Nail. Acad. Sci. USA. 84:8065.
16. Sant, A. J.,and R. N. Germain. 1989. Intracellular competition for component chains
determines class II MHC cell surface phenotype. Cell. 57 :797.
17. Margulies, D. H., G. H. Evans, K. Ozato, R. D. Camerini-Otero, K. Tanaka, E. Appela,
and J. G. Seidman. 1983. Expression of H-213d and H-2Ld mouse major histocompati-
bility antigen genes in L cells after DNA-mediated gene transfer. J. Immunol. 130:463.
18 . Mulligan, R. C ., and P Berg. 1981. Selection for animal cells that express the Escherichia
coli gene coding for xanthine-guanine phosphoribosyltransferase. Proc. Natl. Acad. Sci.
USA. 78:2072 .
19 . Goyert, S. M., and J. Silver. 1983. Further characterization of HLA-DS molecules; im-
plications for studies assessing the role of human Ia molecules in cell interactions and
disease susceptibility. Proc. Nail. Acad. Sci. USA. 80 :5719.
20 . Shaw, S., A. Ziegler, and R. DeMars. 1985. Specificity of monoclonal antibodies directed
against human and murine class II histocompatibility antigens as analyzed by binding
to HLA-deletion mutant cell lines. Hum. Immunol. 12:191.
21 . Goyert, S. M.,J. E. Shively, andJ. Silver. 1982 . Biochemical characterization ofa second
family ofhuman Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules.
J Exp. Med. 156:550.
22 . Adams, T. E., J. G. Bodmer, and W. F. Bodmer. 1983. Production and characterization
of monoclonal antibodies recognizing the chain subunits of human Ia alloantigens. Im-
munology. 50:613.
23. Maloy, W. L., J. E. Coligan, Y. Barra, and G. Jay. 1984. Detection of a secreted form
of the murine H-2 class I antigen with an antibody against its predicted carboxyl ter-
minus. Proc. Natl. Acad. Sci. USA. 81:1216.
24. Graham, F. L., and A. J. Van Der Eb. 1973. A new technique for the assay of infectivity
of human adenovirus 5 DNA. Virology. 52:456.
25. Jacobson, S., R. P. Sekaly, C . L. Jacobson, H. F. McFarland, and E. O. Long. 1989.
HLA class II-restricted presentation of cytoplasmic measles virus antigens to cytotoxic
T cells. J Virol. 63:1756.
26. Southern, P J., and P Berg. 1982. Transformation of mammalian cells to antibiotic re-
sistance with a bacterial gene under control of the SV40 early region promoter. J Mol.
Appl. Genet. 1:327.
27. Tonnelle, C., R. DeMars, and E. O. Long. 1985. DOO: a new 0 chain gene in HLA-D
with distinct regulation of expression. EMBO (Eur. Mol. Biol. Organ.)) 4:2389.
28. Sanger, F, S. Nickler, and A. R. Coulson. 1977. DNA sequencing with chain terminating
inhibitors. Proc. Nail. Acad. Sci. USA. 74:5463.
29 . Laemmli, U. K. 1970. Cleavage of structural proteins during assembly of the head of
bacteriophage T4. Nature (Lond.). 22:680.
30. Thomas, L. J., Q V. Nguyen, W. L. Elliot, and R. E. Humphreys. 1988. Proteolytic
cleavage of I; to p25. J Immunol. 140:2670.
31 . Brown, J. H., T Jardetzky, M. A. Saper, B. Samraoui, P J. Bjorkman, and D. C. Wiley.
1988. A hypothetical model of the foreign antigen binding site of class II histocompati-
bility molecules. Nature (Loud.). 332:845.628
￿
STRUCTURAL REQUIREMENTS FOR CLASS II a/S CHAIN PAIRING
32 . Gorman, C. M ., G. T. Merlino, M. C. Willingham, I. Pastan, and B. H. Howard. 1982.
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced
into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci. USA.
79:6777 .
33. Rassoulzadegan, M., A. Cowie, A. Carr, N. Glaichenhaus, R. Kamen, and F. Cuzin.
1982. The roles of individual polyoma virus early proteins in oncogenic transformation.
Nature (Loud.). 300:713 .
34. Treisman, R., U. Novak, J. Favaloro, and R. Kamen. 1981. Transformation of rat cells
by an altered polyoma virus genome expressing only the middle-T protein. Nature (Lond.).
292:595 .
35 . Cherington, V., B. Morgan, B. M. Spiegelman, and T. M. Roberts. 1986. Recombinant
retroviruses that transduce individual polyoma tumor antigens: effects on growth and
differentiation. Proc. Natl. Acad. Sci. USA. 83:4307.
36. Deans, R. J., K. A. Denis, A. Taylor, and R. Wall. 1984. Expressionof an immunoglob-
ulin heavy chain gene transfected into lymphocytes. Proc. Natl. Acad. Sci. USA. 81:1292.
37 . Mollick, J. A., R. G. Cook, and R. R. Rich. 1989. Class II MHC molecules are specific
receptors for staphylococcus enterotoxin A. Science (Wash. DC). 244:817.
38 . Scholl, P., A. Diez, W. Mourad, J. Parsonnet, R. S. Geha, and T. Chatila. 1989. Toxic
shock syndrome toxin 1 binds to major histocompatibility complex class II molecules.
Proc. Natl. Acad. Sci. USA. 86:4210.